Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.360
+0.020 (1.49%)
At close: Jun 27, 2025, 4:00 PM
1.360
0.00 (-0.01%)
After-hours: Jun 27, 2025, 6:04 PM EDT
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $65.63 million as of June 27, 2025. Its market cap has decreased by -24.86% in one year.
Market Cap
65.63M
Enterprise Value
-41.81M
1-Year Change
-24.86%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $65.63M, a decrease of -88.14%. That is a compound annual growth rate of -39.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 65.63M | -17.07% |
| Dec 31, 2024 | 79.14M | -16.75% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |